Home › Vascular Malformations › NCT03001180

Identification of Biomarkers for Patients with Vascular Anomalies

Who can join

1 Day · All sexes

Inclusion Criteria:

* Any patient having labs drawn as standard of care will have blood drawn for the study if consented/ assented.
* All patients who are undergoing a surgical procedure or sclerotherapy are currently consented for participation in the tissue bank.

Exclusion Criteria:

* N/A

About the study

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Sponsor: Children's Hospital Medical Center, Cincinnati · Participants: 1,000 · Started: 2015-04

Contact the study team

• Timothy LeCras, PhD · Phone: 5138034862

Official record on ClinicalTrials.gov — NCT03001180

Locations in the U.S.

Conditions

• Vascular Malformations

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.